Member Info for 13thmonkey

Or they are doing this to sell more tinfoil.

You could also say 25% down on no news on the earlier weeks, it's just a fluctuation.

Doctor100, the link provided clearly states that this was in the vaccine trial, and not the vaccine rollout, so the couple of thousand people who were a part of the trial a proportion of those are not actually vaccinated, not a proportion of everyone who has every been vaccinated.

So you're ignoring your blatant bs about 40%.

The outcome of the final paper should then be a larger purposeful experiment, on humans, that'll take years. Doesn't mean it's not being arranged. It'll need to be better than moderate evidence.

American not NHS as you stated. Self reported survey, there will be a bias towards those that want to shout about not taking it. Sample size at 711 it comedically low. Think critically about the data you present.

An actual study into ivermectin and not the ramblings of a conspiracy theorist. "Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials | Clinical Infectious Diseases | Oxford Academic" https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab591/6310839

https://www.itv.com/news/central/2021-05-26/how-many-nhs-hospital-staff-have-had-the-covid-vaccine-coronavirus-vaccination-hesitancy-injection-pandemic

40% I call BS on that. worst case trust seems to be 27% with many <10%.

It could be several tests used by exception based on the anterior nasal swab.

Real and honest answer you diversify, now. If you have to sell something you sell it. But that's your choice.

here =/= hear

The 'system' that I think everyone was expecting at last Septembers? Announcement was a more functional tube, not just a saline squirt but the analysis in the tube not in a standalone machine. If there is an analyser small enough and cheap enough that they become ubiquitous then that's a very interesting place to be.

Microtox bt never needed msys in its first iterations, not sure how it looks now.

£400k a week, off an intermediate state 3m capacity a week I don't see a problem (even at 3m a month the answers the same). Even at £1 per test revenue (far more interested in profit personally) that's actually not much volume, at more realistic sales prices the volume is obviously lower. There will be other tests beside covid coming through. All in all I see no problem there, unless of course you want them to be doing that by next week. In which case the footy might be a better place to put your money for the instant gratification.

If the MF recommends a stock today, within a week there'll be an article stating the opposite.

Or technically a breakout looks likely, if enough people believe that and act accordingly then it becomes true.

I came at it from a different, simpler and more naive angle and got similar enterprise valuations, just working from an estimate of manufacturing capacity a simple £1 profit per test, and ratio it up. There is an assumption that other tests types will come on stream over time replacing conventional tests at doctors and hospitals.

Someone definitely got caught out. I wouldn't want ABD to have a gov contract, not with the UK gov anyway. But we're a manufacturer for someone else who is doing the selling.

ah, the sheer quality of the indian test, you can smell the quality from here. Been caught out have we?

Upomega, 3m per week is more than I was expecting, thanks, just trying to work out a range of profitabilities.

Does anyone know what manufacturing capacity we actually have at the moment and are likely to have in the future?